Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.32 |
| ▸ | PDK2 | Q15119 | 4/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21895075 | 0.92 | ESR1 (0.36) | ESR1ESR2KDM4EMEN1LMNA | |
| SCHEMBL22923284 | 0.92 | NFE2L2 (0.34) | ESR1ESR2KDM4EMEN1LMNA | |
| SCHEMBL22923266 | 0.91 | PDK2 (0.33) | ESR1ESR2PDK2 | |
| SCHEMBL23638830 | 0.91 | PDK2 (0.34) | ESR1ESR2KDM4EMEN1LMNA | |
| SCHEMBL22923270 | 0.91 | NFE2L2 (0.36) | ESR1ESR2KDM4EMEN1LMNA | |
| SCHEMBL24336364 | 0.91 | PDK2 (0.33) | PDK2 | |
| SCHEMBL24614519 | 0.90 | PDK2 (0.38) | ESR1ESR2KDM4EMEN1LMNA | |
| SCHEMBL24248253 | 0.90 | PDK2 (0.33) | ESR1ESR2PDK2 | |
| SCHEMBL22923281 | 0.90 | ESR1 (0.33) | ESR1ESR2KDM4EMEN1LMNA | |
| SCHEMBL22923267 | 0.90 | ESR1 (0.35) | ESR1ESR2KDM4EMEN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024096610-A1 | INK COMPOSITION, ORGANIC MATERIAL LAYER COMPRISING SAME, AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | 주식회사 엘지화학 | 2024-05-10 | — | — | WO | disclosed |
| US-20230309369-A1 | Organic Light-Emitting Device | LG CHEM, LTD. (KR) | 2023-09-28 | — | — | US | disclosed |
| US-20230309369-A1 | Organic Light-Emitting Device | LG CHEM, LTD. (KR) | 2023-09-28 | — | — | US | disclosed |
| EP-4181224-A1 | ORGANIC LIGHT-EMITTING DEVICE | Lg Chem, Ltd. (KR) | 2023-05-17 | — | — | EP | disclosed |
| US-20220064101-A1 | Novel Compound and Organic Light Emitting Device Comprising the Same | LG CHEM, LTD. (KR) | 2022-03-03 | — | — | US | disclosed |
| EP-3954677-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | LG Chem, Ltd. (KR) | 2022-02-16 | — | — | EP | disclosed |
| WO-2021015522-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | 주식회사 엘지화학 | 2021-01-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220064101-A1 | Novel Compound and Organic Light Emitting Device Comprising the Same | ARL1, LAS1L, ARRB1 | ESR1 38/4885ESR2 63/4885KDM4E 3813/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.